S-1 and Oxaliplatin

DRUG2 trials

Sponsors

Sixth Affiliated Hospital, Sun Yat-sen University, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

Esophageal CancerGastric Adenocarcinoma

Phase 1

Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer

CompletedNCT02347904

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Esophageal Cancer

Start: 2014-12-31End: 2019-11-30Updated: 2019-11-18

Phase 2

Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma

Sixth Affiliated Hospital, Sun Yat-sen UniversityGastric Adenocarcinoma

Start: 2012-03-31End: 2014-02-28Target: 30Updated: 2012-03-28